EcoDrugPlus

Coiled-Coil Domain Containing 6

Ensembl ID : ENSMAUG00000005713
Gene Symbol: CCDC6
4 Cross references
219 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSMAUG00000009005
Gene Symbol: CSF1R
4 Cross references
206 Possible Orthologues:

Complement C1s

Ensembl ID : ENSMAUG00000017562
Gene Symbol: C1S
3 Cross references
199 Possible Orthologues:

Complement Factor D (Adipsin)

Ensembl ID : ENSMAUG00000016914
Gene Symbol: CFD
1 Cross references
133 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSMAUG00000016666
Gene Symbol: CRHR1
2 Cross references
240 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSMAUG00000017636
Gene Symbol: CCND1
4 Cross references
277 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSMAUG00000020301
Gene Symbol: CDK1
4 Cross references
231 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSMAUG00000019327
Gene Symbol: CDK2
3 Cross references
202 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSMAUG00000010648
Gene Symbol: CDK4
4 Cross references
209 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSMAUG00000016278
Gene Symbol: CDK5
4 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSMAUG00000021142
Gene Symbol: CDK6
3 Cross references
198 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSMAUG00000020488
Gene Symbol: CDK9
4 Cross references
207 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).